| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |